CURE Pharmaceutical [OTC: CURR] Expands Highly Valuable Medication Patent Portfolio; Marketing Expansion to Mexico, Plus New Product

The patents represent an expansion of the existing CURR “product by process” patents for obtaining multiple unique concentrates using super critical fluid extraction (SCFE).